INS and diabetes mellitus: Bench-side dose accuracy results for an Ultra Low Cost Insulin Pump (ULCIP) were presented in the Journal of Diabetes Science Technology in December 2022 [13], with an in depth presentation of the open-source hardware published in HardwareX [14].